Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML

Research output: Contribution to journalLetterpeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Case report of combination therapy with Azacytidine, Enasidenib and Venetoclax in primary refractory AML'. Together they form a unique fingerprint.

Medicine & Life Sciences